BIOSIMILARS CONGRESS INDIA 2018

Testimonials

"Sessions on Clinical Development, strategies, market access were very good"
Debashish Dutta
Associate Director
Dr. Reddy's Laboratories Ltd.
"There were lot of topics which were very useful. It helped us understand the current scenario in India and across the world about the biosimilar programs. Gave valuable inputs on regulatory expectations and biotech industries approach towards attaining a FDA certification"
Jiju Kumar P
Associate Director
Kemwell Biopharma Pvt Ltd
"The event was well organized and a good combination of some interesting speakers and great networking opportunity amongst the companies attending. Also Understood regulatory pathways and regulations for Bio-similar products."
Sunil Dolia
Sr. Manager
CPL Biologicals Pvt Limited
"These kind of conferences are always useful for industry people. The expert had given good insight on various points not known to me. I met with my previous industry colleagues as well as met with new people to establish good network in biosimilars industry. overall the conference was very good."
Puneet Kumar Doshi
Regulatory Affairs
Serum Institute of India Pvt. Ltd.
" I Learn most of new things regarding filling of products in US & Europe "
Gajanan Deshmukh
DRA
Wockhardt Limited
"The presentation delivered during the sessions gave comprehensive idea about the market, analyticals, clinical trials of biosimilars in India and over the globe"
Dr. Mamata Katdare
Deputy General Manager
Unichem Laboratories Ltd. Goa
"1.Got information on the biosimilarity requirements for USFDA based on industry experience. Expectations for Analytical similarity requirements. 2. Clarity on clinical trial requirements for below 40 amino acid biologicals 3. Networking with the delegates"
Ms. Shoba Shenoy
Senior Asst General Manager - Biologics
USV Private Ltd
"The conference proved a great opportunity to meet with a diversity of people across the Biosimilars development pipeline and share ideas"
Richard Easton
Technical Director
BioPharmaSpec
"Theconferenceprovidedagreatplatformtointeractwiththescientists,regulatorsandthemanufacturers."
Shrikrishna Dadke
Vice President
Vimta Labs Ltd.
"Itwasveryinformativeandanexcellentopportunitytounderstandchallengesofbiosimilarsandregulatoryexpectation"
Amarnath Jaiswal
Associate Vice President
Mylan Laboratories Limited
"Got information on the biosimilarity requirements for USFDA based on industry experience. Expectations for Analytical similarity requirements. Clarity on clinical trial requirements for below 40 amino acid biologicals. An Opportunity to network with the delegates"
Shoba Shenoy
Senior Asst General Manager - Biologics
USV Private Ltd